Cargando…

Identification of miR-34a as a potent inhibitor of prostate cancer progenitor cells and metastasis by directly repressing CD44

Cancer stem cells (CSCs) or tumor progenitor cells are involved in tumor progression and metastasis1. MicroRNAs (miRNAs) regulate both normal stem cells and CSCs2–5 and miRNA dysregulation has been implicated in tumorigenesis6. CSCs in many tumors, including cancers of the breast7, pancreas8, head a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Can, Kelnar, Kevin, Liu, Bigang, Chen, Xin, Calhoun-Davis, Tammy, Li, Hangwen, Patrawala, Lubna, Yan, Hong, Jeter, Collene, Honorio, Sofia, Wiggins, Jason F., Bader, Andreas G., Fagin, Randy, Brown, David, Tang, Dean G.
Formato:	Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076220/ https://www.ncbi.nlm.nih.gov/pubmed/21240262 http://dx.doi.org/10.1038/nm.2284

Ejemplares similares

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)

miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells
por: Liu, Ruifang, et al.
Publicado: (2016)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice
por: Chen, Xin, et al.
Publicado: (2013)

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
por: Liu, Xin, et al.
Publicado: (2015)

In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
por: Zhao, Jane, et al.
Publicado: (2014)

Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44(+) Cells and Evidence for Epigenetic Mechanisms
por: Yan, Hong, et al.
Publicado: (2011)

In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals
por: Badeaux, Mark A, et al.
Publicado: (2013)

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2020)

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2019)

Plant responses to extracellular nucleotides: Cellular processes and biological effects
por: Jeter, Collene R., et al.
Publicado: (2006)

Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model
por: Liu, Bigang, et al.
Publicado: (2017)

Nanog1 in NTERA-2 and Recombinant NanogP8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species
por: Liu, Bigang, et al.
Publicado: (2014)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Da Vinci prostatectomy: athermal nerve sparing and effect of the technique on erectile recovery and negative margins
por: Fagin, Randy
Publicado: (2007)

Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration
por: Zhang, Dingxiao, et al.
Publicado: (2017)

Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Li, Jia, et al.
Publicado: (2015)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44(hi) Stem-Like NSCLC Cells
por: Shi, Yang, et al.
Publicado: (2014)

The timing and route of seminal vesicle dissection during robotic prostatectomy
por: Lee, David I., et al.
Publicado: (2007)

SPINDOC binds PARP1 to facilitate PARylation
por: Yang, Fen, et al.
Publicado: (2021)

4,4′-Bis[2-(3,4-dibutyl-2-thienylethynyl)]biphenyl
por: Liu, Lei, et al.
Publicado: (2008)

PDL1 Regulation by p53 via miR-34
por: Cortez, Maria Angelica, et al.
Publicado: (2015)

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
por: Hong, David S., et al.
Publicado: (2020)

Quantification of Therapeutic miRNA Mimics in Whole Blood from Nonhuman Primates
por: Kelnar, Kevin, et al.
Publicado: (2014)

Regression of murine lung tumors by the let-7 microRNA
por: Trang, Phong, et al.
Publicado: (2009)

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
por: Tivnan, Amanda, et al.
Publicado: (2011)

The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding
por: Ferguson, Brent W, et al.
Publicado: (2013)

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
por: Li, Wen (Jess), et al.
Publicado: (2021)

miR-34 – a microRNA replacement therapy is headed to the clinic
por: Bader, Andreas G.
Publicado: (2012)

CD117(+)CD44(+) Stem T Cells Develop in the Thymus and Potently Suppress T-cell Proliferation by Modulating the CTLA-4 Pathway
por: Wei, Yang, et al.
Publicado: (2017)

The CD34-Related Molecule Podocalyxin Is a Potent Inducer of Microvillus Formation
por: Nielsen, Julie S., et al.
Publicado: (2007)

Benzylidene-6-hydroxy-3,4-dihydronaphthalenone chalconoids as potent tyrosinase inhibitors
por: Ranjbar, Sara, et al.
Publicado: (2021)

Novel PI3Kγ Mutation in a 44-Year-Old Man with Chronic Infections and Chronic Pelvic Pain
por: Bojarski, Emeric F., et al.
Publicado: (2013)

CERN/LHCC 95-44 LRDB status report RD34, 16 August 1995
por: CERN. Geneva
Publicado: (1995)

Dipotassium 4,4′-(hexane-3,4-diyl)bis(benzenesulfonate) dihydrate
por: Orola, Liana, et al.
Publicado: (2008)

Crystal structure of 4,4-dibutyl-2-phenyl-3,4-dihydroquinazoline
por: El-Hiti, Gamal A., et al.
Publicado: (2014)

Dominant Repression by Arabidopsis Transcription Factor MYB44 Causes Oxidative Damage and Hypersensitivity to Abiotic Stress
por: Persak, Helene, et al.
Publicado: (2014)

Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
por: Zheng, Fang, et al.
Publicado: (2015)

Resveratrol analogue 4,4′-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis
por: Savio, Monica, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4vu36kul5en9h4g2d5i574hhtg